Assessment of Empagliflozin as Adjuvant Therapy in Patients With Ulcerative Colitis

NCT05058417 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Institutional and funding constrains

Conditions

Ulcerative Colitis

Interventions

DRUG: Empagliflozin 10 MG
DRUG: Placebo

Sponsor

Sadat City University